Jan Oudenes

This inventor holds 18 USPTO granted patents and 5 published patent applications, plus 8 CIPO patents and 7 EPO patents. Top assignees: Akebia Therapeutics, Inc., Torcan Chemical Ltd, Alphora Research Inc.. Active years: 1989-2026.

USPTO Granted Patents = 18 (Patent Applications = 5)

% Patents Active = 72.2

CIPO Patents = 8

EPO Patents = 7 (Patent Applications = 8)

Average Co-Inventor Count = 4.0

ph-index = 5

Forward Citations = 92(Granted Patents)

Location History:

Thornhill, CA (1989 - 1998)
Aurora, CA (2001 - 2022)

Company Filing History:

6 out of 37

Akebia Therapeutics, Inc.

Alphora Research Inc.

patents

4. 1 out of 35

Aerpio Therapeutics, Inc.

Stealth Biotherapeutics Inc.

patents

Years Active: 1989-2026

Loading Chart...

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12673919 - Process for preparing [(3-hydroxypyridine-2-carbonyl)aminojalkanoic acids, esters and amides (2026-07-07),

2. 11267785 - Process for preparing [(3-hydroxypyridine-2-carbonyl)amino]alkanoic acids, esters and amides (2022-03-08),

3. 10961273 - N-carboxyanhydride-based-scale synthesis of elamipretide (2021-03-30),

4. 10738010 - Process for preparing [(3-hydroxypyridine-2-carbonyl)amino] alkanoic acids, esters and amides (2020-08-11),

5. 10246416 - Process for preparing [(3-hydroxypyridine-2-carbonyl)amino] alkanoic acids, esters and amides (2019-04-02),

6. 9776969 - Process for preparing [(3-hydroxypyridine-2-carbonyl)amino]alkanoic acids, esters and amides (2017-10-03),

7. 9550716 - Process for treprostinil salt preparation (2017-01-24),

8. 9388135 - Process for preparing N-benzyl-3-hydroxy-4-substituted-pyridin-2-(1H)-ones (2016-07-12),

9. 9145366 - Process for preparing [(3-hydroxypyridine-2-carbonyl)amino]alkanoic acids, esters and amides (2015-09-29),

10. 8513441 - Prostaglandin synthesis and intermediates for use therein (2013-08-20),

11. 8309744 - Prostaglandin synthesis and intermediates for use therein (2012-11-13),

12. 7928252 - Prostaglandin synthesis and intermediates for use therein (2011-04-19),

13. 7321047 - Separation of tetrahydrocannabinols (2008-01-22),

14. 6204383 - Processes for preparing sildenafil (2001-03-20),

15. 5783702 - Preparation of cisapride (1998-07-21),

Title: Jan Oudenes: Pioneering Innovations in Chemical Synthesis

Introduction

Jan Oudenes, an esteemed inventor based in Aurora, CA, has made significant contributions to the field of chemical synthesis. With 17 patents to her name, she continues to pioneer advances that hold promise for various therapeutic applications.

Latest Patents

Among her notable recent patents is a process for preparing [(3-hydroxypyridine-2-carbonyl)amino]alkanoic acids, esters, and amides. This invention discloses methods to synthesize derivatives, including 5-aryl and 5-heteroaryl substituted compounds. These advancements are particularly useful for developing prodrugs that act as prolyl hydroxylase inhibitors, contributing to treatments for conditions requiring such inhibition.

Another significant patent involves the N-carboxyanhydride-based scale synthesis of elamipretide (MTP-131), a peptide with therapeutic potential for various mitochondrial myopathies. This innovative methodology utilizes N-carboxyanhydride-modified amino acid residues, improving both the efficiency and purity of the synthetic output.

Career Highlights

Jan has collaborated with leading companies in the pharmaceutical realm, including Akebia Therapeutics, Inc. and Torcan Chemical Ltd. Her extensive experience in these environments has facilitated her innovative research and developments in chemical synthesis.

Collaborations

Throughout her career, Jan has had the privilege of working alongside remarkable colleagues, such as Boris Gorin and Craig Edward Dixon. Their collaborative efforts have further enhanced the scope and impact of her inventions in the industry.

Conclusion

Jan Oudenes exemplifies the spirit of innovation and dedication to advancing science through her extensive portfolio of patents. Her work continues to inspire the next generation of inventors and researchers in the field of chemical synthesis, promising a brighter future for therapeutic development.